CAR t patients monitored for years in new safety study

NCT ID NCT06508775

First seen Nov 01, 2025 · Last updated Jun 02, 2026 · Updated 27 times

Summary

This study follows about 40 people who received Miltenyi CAR T cell therapy at least one year ago. Researchers will track side effects, overall health, and any return of cancer. The goal is to understand the long-term safety of this treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC ALL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Charité Universitätsmedizin Berlin

    RECRUITING

    Berlin, 13353, Germany

  • Uniklinikum Erlangen

    ACTIVE_NOT_RECRUITING

    Erlangen, 91054, Germany

  • Universitäts-Kinderklinik Würzburg

    ACTIVE_NOT_RECRUITING

    Würzburg, 97080, Germany

  • Universitätsklinikum Köln

    ACTIVE_NOT_RECRUITING

    Cologne, 50937, Germany

  • Universitätsklinikum Münster

    RECRUITING

    Münster, 48149, Germany

  • Universitätsklinikum Tübingen

    ACTIVE_NOT_RECRUITING

    Tübingen, 72076, Germany

  • Universitätsmedizin Göttingen

    ACTIVE_NOT_RECRUITING

    Göttingen, 37075, Germany

Conditions

Explore the condition pages connected to this study.